NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

  News | News By Subject | News by Disease News By Date | Search News
   

DuPont (DD) CEO Says Benefits Of Biotechnology Here Today, More On The Way; Progress Being Made On Acceptance, New Applications Of Biotechnology
9/28/2004

TOKYO, Sept. 28 /PRNewswire-FirstCall/ -- DuPont Chairman and Chief Executive Officer Charles O. Holliday, Jr. today said significant progress has been made in demonstrating the benefits of biotechnology, in its acceptance, and in the advancement of new and exciting products the technology is making possible.

"We can now say that biotech has been established as one tool, among many, for feeding the world sustainably - a tool that producers and consumers around the world will increasingly depend on," Holliday said, speaking at Asia's largest biotechnology conference, BioJapan 2004.

He noted that plant biotechnology has been adopted faster than any other technology in the history of agriculture. In eight years, farmers in the United States have converted 81 percent of soybeans, 73 percent of cotton, and 40 percent of corn to biotech varieties. The amount of biotech crops planted globally is increasing every year with the fastest growth coming outside North America.

"Companies can't drive that kind of adoption. It occurs because people see the value," Holliday said.

The value goes well beyond the farmers who choose to grow the crops. Holliday said that many overlook the importance of productivity improvements that biotechnology is helping sustain. "Where would we be today, if in 1950 someone had decided we had enough grain in the world and we had stopped investing in improved genetics?" he asked.

"Since 1980, the world's corn growers have increased their production by 45 percent and done it on less than a 5 percent increase in acres. In effect, we've added 130 million 'virtual' acres by improving corn genetics, technology, and management practices. Think of the impact on our world if we did not have those 130 million 'virtual' acres," Holliday said.

Both large and small farmers are using biotechnology today to grow more while reducing the spraying they need to do, Holliday said. And there are many other benefits on the horizon.

Biotechnology is allowing DuPont to develop products like drought- resistant crops, bio-fuels and biomaterials, Holliday said. The benefits in industrial applications could far outstrip the contribution of biotechnology to medicine and agriculture.

"We are working to create new manufacturing platforms based on biotechnology that significantly lower cost and investment or offer an improved environmental performance," said Holliday. "We are solving problems that cannot be solved by existing approaches."

Holliday acknowledged that the technology is not without its critics and challenges. But he said DuPont continues to be committed to pursuing the promise of biotechnology for its customers in a careful and transparent manner. "We understand that continued open and transparent dialogue with consumers and governments will be necessary for this tool - biotechnology - to achieve its maximum utility," he said.

The company formed an external global Biotechnology Advisory Panel in 2000, which helped the company create its Bioethics Guiding Principles. The DuPont Biotechnology Advisory Panel is in the process of completing its second independent report on DuPont and its application of biotechnology. A listing of advisory panel members, their reports, and the DuPont Bioethics Guiding Principles, and extensive information on its biotech products are available at http://www.dupont.com/biotech.

"We are convinced that biotechnology can and is being employed successfully and safely to the benefit of people everywhere," Holliday said. "It will make great contributions to meeting human needs in the 21st century."

The full text of the Holliday remarks prepared for delivery at BioJapan 2004 is available at http://www1.dupont.com/NASApp/dupontglobal/corp/index.jsp?page=/content/US/en_ US/news/speeches/index.html.

DuPont is a science company. Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. Operating in more than 70 countries, DuPont offers a wide range of innovative products and services for markets including agriculture, nutrition, electronics, communications, safety and protection, home and construction, transportation, and apparel.

DuPont

CONTACT: Doyle Karr, DuPont, +1-515-270-3428, doyle.karr@pioneer.com



Read at BioSpace.com

DuPont
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES